MAP KINASE 2/ERK2 INACTIVE 50UG

Catalog No.: C005B-095514
Mfr. No.: 14-198
Mfr. Name: Sigma-Aldrich
Qty/UOM: 50
UOM: UG

Price: $1,075.88

List Price: $1,195.43

Product Source: expressed in E coli Recombinant full-length mouse p42 MAP Kinase 2/Erk2 fused with GST at the N terminus Quality routinely evaluated by phosphorylation of MBP (Catalog # 13-104) substrate in vitro. Other Notes For Specific Activity

Enjoy exclusive benefits including discounted pricing on orders by contacting our Sales Executives to open an account. Contact Us

Current Stock:

Quantity:

Adding to cart… The item has been added

Description
Specifications

General description

Product Source: expressed in E coli

Recombinant full-length mouse p42 MAP Kinase 2/Erk2 fused with GST at the N terminus

Quality

routinely evaluated by phosphorylation of MBP (Catalog # 13-104) substrate in vitro.

Other Notes

For Specific Activity data, refer to the Certificate of Analysis for individual lots of this enzyme.

Legal Information

UPSTATE is a registered trademark of Merck KGaA, Darmstadt, Germany

Shipping Information:

Dry Ice Surcharge & Ice Pack Shipments: $40

More Information: https://cenmed.com/shipping-returns

UPC:: 51202000
Condition:: New
Availability:: 3-5 Days
Weight:: 1.00 Ounces
HazmatClass:: No
MPN:: 14-198
Temperature Control Device:: Yes

Cenmed Satisfaction Guarantee

At Cenmed, your confidence and satisfaction are paramount. We guarantee the quality and reliability of our extensive range of clinical and laboratory supplies. If you're not completely satisfied with your purchase, we offer a straightforward return process and dedicated support to resolve your concerns promptly. Our commitment ensures that you can order with confidence, knowing that Cenmed is dedicated to superior service and customer satisfaction. Trust us to meet your needs with every order, backed by our promise of excellence. Learn more in Help & FAQs.

"Cenmed provides me access to the same products/services normally reserved for much larger labs than mine. I was presently surprised by their product offering."